Y-Intercept (Hong Kong) Ltd

Position in HLN — Haleon plc

CIK 1772875 HONG KONG, K3

Position in HLN

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$939,158

+$607,090 QoQ

Shares Held

93,822

+193.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Y-Intercept (Hong Kong) Ltd holds $31,681,893 across 15 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	302,995	$9,126,209
2	VTRS	Viatris Inc	525,863	$7,104,409
3	PRGO	PERRIGO Co plc	447,451	$4,805,623
4	BIOA	BioAge Labs, Inc.	201,337	$3,521,384
5	ZTS	Zoetis Inc.	15,837	$1,872,091
6	SUPN	Supernus Pharmaceuticals, Inc.	20,236	$1,045,998
7	HLN	Haleon plc This page	93,822	$939,158
8	XERS	Xeris Biopharma Holdings, Inc.	161,793	$938,399

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$939,158	93,822	+193.0%	Shares	Sole	2026-04-27
2025-06-30	$332,068	32,022	-55.8%	Shares	Sole	2025-08-01
2025-03-31	$744,728	72,374	+27.5%	Shares	Sole	2025-05-06
2024-09-30	$600,436	56,752	-47.8%	Shares	Sole	2024-11-15
2024-03-31	$922,260	108,629	+740.4%	Shares	Sole	2024-05-10
2023-12-31	$106,380	12,926	+16.7%	Shares	Sole	2024-02-13
2023-06-30	$92,783	11,072	-82.2%	Shares	Sole	2023-08-14
2023-03-31	$507,651	62,365	-63.8%	Shares	Sole	2023-05-09
2022-12-31	$1,378,232	172,279	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.